Coenzyme Q10 in the Treatment of Corneal Edema in Kearns-Sayre: Is There an Application in Fuchs Endothelial Corneal Dystrophy?

Cornea 2016 Sep;35(9):1250-4

*University of Pittsburgh School of Medicine, Pittsburgh, PA; †Pediatric Ophthalmology, Strabismus and Adult Motility, UPMC Eye Center, Children's Hospital of Pittsburgh, Pittsburgh, PA; ‡Drexel University College of Medicine, Philadelphia, PA; §Clinical and Academic Department of Ophthalmology, Great Ormond Street Hospital for Children, London, United Kingdom; and ¶UPMC Eye Center, Pittsburgh, PA.

Purpose: Corneal involvement in mitochondrial disease is seldom described. Kearns-Sayre syndrome (KSS) is a mitochondrial disorder characterized by retinitis pigmentosa, external ophthalmoplegia, and heart block. We report 2 patients with KSS with corneal lesions involving the endothelium, which improved with Coenzyme Q10 (CoQ10). Based on recent research regarding the role of dysfunctional oxidative metabolism in Fuchs Endothelial Corneal Dystrophy (FECD), we propose that mitochondrial diseases and FECD share a final pathway.

Methods: A chart review was performed and a review of the literature was completed with a PubMed search using the terms "Kearns-Sayre Syndrome", "mitochondria", "endothelium", "Fuchs endothelial corneal dystrophy", and "cornea".

Results: There are 19 reports of corneal involvement in clinical phenotypes of mitochondrial disease. Nine of these 19 cases had findings consistent with KSS. Our patients with KSS had microcystic changes throughout the cornea and excrescences on the endothelial surface seen with ultrasound biomicroscopy, similar to the clinical findings in FECD. CoQ10 improved corneal disease in both children. CoQ10 deficiency has been reported in a variety of mitochondrial diseases, and efficacy of supplementation has been demonstrated. It may be beneficial in these patients because of its antioxidant properties and role in oxidative phosphorylation.

Conclusions: The common deletion found in patients with KSS has recently been implicated in FECD, which has recently been shown to be a disease related to dysfunctional oxidative metabolism. Future research should explore the use of antioxidants, such as CoQ10 in patients with FECD.

Download full-text PDF

Source
http://dx.doi.org/10.1097/ICO.0000000000000927DOI Listing
September 2016

Publication Analysis

Top Keywords

endothelial corneal
12
patients kss
12
fuchs endothelial
8
dysfunctional oxidative
8
mitochondrial disease
8
oxidative metabolism
8
corneal involvement
8
coenzyme q10
8
corneal
8
mitochondrial diseases
8
patients
5
kss
5
fecd
5
mitochondrial
5
clinical phenotypes
4
reports corneal
4
dystrophy" "cornea"results
4
"cornea"results reports
4
phenotypes mitochondrial
4
involvement clinical
4

Similar Publications